TPC Group Gets Higher Offer from First Reserve, SK Capital

Chemical maker TPC Group said private equity firms First Reserve and SK Capital Partners raised their offer price for the company by 12.5%, days after it got a rival proposal from Innospec.

The offer has been raised by $5 to $45 per share, valuing TPC at $705.5 million.

The company said it had ended negotiations with Innospec, which last month offered $44 to $46 per share in cash.

The TPC board recommended that shareholders vote in favor of the latest offer from the two private equity firms.

The company, which produces butadiene used in making synthetic rubber for tires and other automotive products, has seen a sharp fall in prices in recent months due to weak demand.

The bidders, however, are betting on a long-term shortage in butadiene.

Butadiene is a byproduct of the process of making ethylene and its supply is likely to dip as companies shift to cheaper natural gas liquids such as ethane to produce ethylene.

TPC stock has risen nearly 12% since Aug. 27, when First Reserve and SK Capital made their first bid.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.